Recall Record

Tarrytown, NY, United States

Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company recalls

3 recalls recorded since 2018, most recently on 15 September 2026. 1 is listed as ongoing. Status and classification are as published by the FDA.

Recalls3
Ongoing (FDA)1
Terminated or completed2
Class I (FDA)2

Ongoing Class II Drugs

Recall started
15 September 2026
Reason
Lack of Assurance of Sterility
Distribution
Nationwide in the USA.
Initiated
Voluntary: Firm initiated
Recall numbers
D-0871-2026, D-0870-2026

Completed Class I Drugs

Recall started
1 February 2024
Reason
Chemical Contamination; presence of benzene.
Distribution
Product was distributed nationwide and to 4 foreign accounts. Guaynabo, Puerto Rico; Georgetown, Guyana; Baghdad, Iraq; Accra, Ghana.
Initiated
Voluntary: Firm initiated
Recall number
D-0346-2024

Completed Class I Drugs

Recall started
21 December 2023
Reason
Chemical Contamination: presence of benzene
Distribution
Nationwide in the USA
Initiated
Voluntary: Firm initiated
Recall number
D-0236-2024

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.